Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April K S Salama

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Clinical Medicine Insights. Oncology|July 12, 2013
Evolving pharmacotherapies for the treatment of metastatic melanomaApril K S Salama
Expert Opinion on Pharmacotherapy|February 26, 2013
Trametinib (GSK1120212) in the treatment of melanomaApril K S Salama, Kevin B Kim
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2011
Cytotoxic T-lymphocyte-associated antigen-4April K S Salama, F Stephen Hodi
JCO Oncology Practice|February 23, 2022
A Marathon Not a Sprint: Improving Outcomes for Patients With Metastatic Melanoma in 2022 and BeyondLucy Boyce Kennedy, April K S Salama
Oncology and Therapy|July 24, 2020
A Review of Immune-Mediated Adverse Events in MelanomaLucy Boyce Kennedy, April K S Salama
Cancers|January 20, 2016
Updates in Therapy for Advanced MelanomaBhavana P Singh, April K S Salama
Current Oncology Reports|June 5, 2024
Multiple Options: How to Choose Therapy in Frontline Metastatic MelanomaLucy Boyce Kennedy, April K S Salama
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2013
BRAF in melanoma: current strategies and future directionsApril K S Salama, Keith T Flaherty
CA: a Cancer Journal for Clinicians|January 17, 2020
A review of cancer immunotherapy toxicityLucy Boyce Kennedy, April K S Salama
Current Oncology Reports|August 27, 2013
MEK inhibition in the treatment of advanced melanomaApril K S Salama, Kevin B Kim
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Clinical Medicine Insights. Oncology|July 12, 2013
Evolving pharmacotherapies for the treatment of metastatic melanomaApril K S Salama
Expert Opinion on Pharmacotherapy|February 26, 2013
Trametinib (GSK1120212) in the treatment of melanomaApril K S Salama, Kevin B Kim
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2011
Cytotoxic T-lymphocyte-associated antigen-4April K S Salama, F Stephen Hodi
JCO Oncology Practice|February 23, 2022
A Marathon Not a Sprint: Improving Outcomes for Patients With Metastatic Melanoma in 2022 and BeyondLucy Boyce Kennedy, April K S Salama
Oncology and Therapy|July 24, 2020
A Review of Immune-Mediated Adverse Events in MelanomaLucy Boyce Kennedy, April K S Salama
Cancers|January 20, 2016
Updates in Therapy for Advanced MelanomaBhavana P Singh, April K S Salama
Current Oncology Reports|June 5, 2024
Multiple Options: How to Choose Therapy in Frontline Metastatic MelanomaLucy Boyce Kennedy, April K S Salama
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2013
BRAF in melanoma: current strategies and future directionsApril K S Salama, Keith T Flaherty
CA: a Cancer Journal for Clinicians|January 17, 2020
A review of cancer immunotherapy toxicityLucy Boyce Kennedy, April K S Salama
Current Oncology Reports|August 27, 2013
MEK inhibition in the treatment of advanced melanomaApril K S Salama, Kevin B Kim
Pageof 7